UBS Group
STDY

UBS Group’s SteadyMed Ltd STDY Stock Holding History

UBS Group’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-505
Closed -$2K – 8500
2018
Q1 		$2K Sell
505
-1,060
-68% -$3.5K ﹤0.01% 7598
2017
Q4 		$6K Buy
1,565
+27
+2% +$87 ﹤0.01% 7346
2017
Q3 		$5K Buy
+1,538
New +$8.18K ﹤0.01% 7268
2016
Q4 		– Sell
-3,162
Closed -$11K – 8262
2016
Q3 		$11K Sell
3,162
-1,937
-38% -$6.62K ﹤0.01% 6749
2016
Q2 		$17K Buy
5,099
+2,718
+114% +$9.48K ﹤0.01% 6434
2016
Q1 		$6K Sell
2,381
-2,170
-48% -$5.4K ﹤0.01% 6962
2015
Q4 		$15K Buy
4,551
+2,040
+81% +$6.14K ﹤0.01% 7030
2015
Q3 		$9K Buy
2,511
+638
+34% +$2.91K ﹤0.01% 7367
2015
Q2 		$10K Buy
+1,873
New +$15.1K ﹤0.01% 7497

Other funds holding STDY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

UBS Group's STDY Position: Q2 2018 in Review

UBS Group sold out of SteadyMed Ltd (STDY) in Q2 2018, closing a stake of 505 shares — an estimated $2K sold.

UBS Group first reported a position in STDY in Q2 2015 and held it in 9 quarters. The position peaked at $17K in Q2 2016. 30 funds tracked by Wall St. Rank hold STDY as of Q2 2018.

  • UBS Group reported no remaining SteadyMed Ltd position as of Q2 2018 after selling out during the quarter.
  • UBS Group sold 505 SteadyMed Ltd shares in Q2 2018, an estimated $2K.
  • UBS Group first reported a position in SteadyMed Ltd in Q2 2015 and held it in 9 quarters.
  • UBS Group's SteadyMed Ltd position peaked at $17K in Q2 2016.
  • 30 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q2 2018.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.